13^th Asia-Pacific Oncologists Annual Meeting October 17-19, 2016 Kuala Lumpur, Malaysia

Dr.Peng Huang is currently a Professor with joint appointment as a Principal Investigator in State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center (SYSUCC). Dr. Huang received his medical degree from Sun Yat-sen University School of Medicine in 1982 and his Ph.D. degree from the Graduate School of Biomedical Sciences, University of Texas-Houston in 1990. He joined the faculty of University of Texas MD Anderson Cancer Center as an Assistant Professor in 1995, was promoted to Associate Professor in 2001, and became a Professor with tenure at MD Anderson Cancer Center in 2007. Dr Huang was honored as a Chang Jiang Visiting Professor in SYSUCC by the Chinese Ministry of Education in 2008, and elected as a member of the “Thousand Talents Program” in 2010.

Dr. Huang’s research focuses on cancer metabolism and oxidative stress, anticancer agents, and experimental cancer therapeutics. He has made significant discoveries in the area of redox alterations in cancer cells, leukemia-stromal cells interactions, elevated glycolysis in tumor cells, and novel therapeutic strategies and new anticancer agents. Dr. Huang has published more than 100 peer-reviewed research articles in high-impact journals including Nature, Cell, Cancer Cell, Natural Review Drug Discovery, Nature Cell Biology, JNCI, EMBO J, J Cell Biology, Blood, and Cancer Research.

Head of the Laboratory of Immune-Hematology IBYME,Professor associated charge of immunology.

Immune-Hematology

Rajendra Sharma is a Research Associate Professor in Molecular Biology and Immunology, University of North Texas. He he was a Research fellow, Rajasthan University, Jaipur, India (1975-1979). Research Associate, All India Institute of Medical Sciences, New Delhi (1980-1981). Post-doctoral fellow (1989-1991). Suptdg. Chemist at KDMIPE, Dehradun, India ( April 1991- March 2000). Visiting Scientist at UTMB, Galveston, TX (April 2000-Sept. 2003). Suptdg, Chemist at KDMIPE, Dehradun, India (Oct 2003- Aug.2005).

Chemoprevention of Cancer by natural products: These studies are focused on the role of lipid peroxidation in the mechanisms of cancer prevention and cell killing by sulforaphane, curcumin and Withaferin A.

Nira Ben-Jonathan, Professor of Cancer and Cell Biology, received her undergraduate degree from Tel Aviv University in Israel and a Doctor of Philosophy Degree from the University of Illinois. She was a postdoctoral fellow at the University of Texas and a faculty member in the Department of Physiology at the Indiana University Medical School; she joined the University of Cincinnati as Professor in 1992

Control of prolactin, LH and GH synthesis and secretion, posterior pituitary hormones, catecholamines in the hypothalamo-pituitary-ovarian axis.

Dr. Aggarwal is a Ransom Horne, Jr. Distinguished Professor of Cancer Research, Professor of Cancer Medicine, Professor of Immunology, Professor of Biochemistry and Professor of Experimental Therapeutics, and Chief, Cytokine Research Section, in the Department of Experimental Therapeutics at the University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Immunology,Biochemistry,Experimental Therapeutics

Dr. Masahiro Hiraoka, Directing Professor of the Department of Radiation Oncology and Image Applied Therapy, is a pioneer in the development of 1oco-regional cancer therapy, especially 3D conformal beam radiotherapy. His specialties include stereotactic radiotherapy for the treatment of solitary pulmonary tumors, IMRT for treating prostate cancer, and other 3D conformal beam radiotherapies.

Stereotactic radiotherapy, Prostate cancer

Dr. Sarkar has been interested in understanding the role of NF-κB and its upstream and downstream signalling molecules in solid tumors, and in elucidating the molecular mechanisms of action of natural agents for cancer prevention and therapy.

Prostate cancer, breast cancer, pancreas cancer, head & neck cancer, ovarian cancer, and lung cancer.

Dr. Ahmed El-Sharkawy completed his Ph.D. in Molecular Oncology at the age of 27 years from Alexandria University. He is an adjunct Research Scientist, Molecular therapeutics laboratory, and City of Research and Technology applications and currently an professor of Biochemistry and Molecular Biology in Alexandria University; I have published more than 15 papers in reputed journals and serving as an editorial board member of Journal of Genetic Syndromes and Gene Therapy, African Journal of Biochemistry Research and Biotechnology and Molecular Biology Reviews.

Biotechnology and Molecular Biology Reviews

Jun Zhu, PhD is a professor in Department of Genetics and Genomic Sciences and a member of Institute of Genomics and Multiscale Biology. Dr. Zhu was trained in both computer science and biomedical science. His research focuses on methodologies for integrating diverse data (e.g. genetic, genomic, transcriptomic, proteomic data and etc.) into probabilistic graphic networks for elucidating complex human diseases, as well as method development for analyzing and comparing disease-related networks. Before joining Mount Sinai, he worked in both industry (Amgen, Inc, and Rosetta/Merck & CO, Inc) and academia (Sage Bionetworks, and Fred Hutchinson Cancer Research Center).

Genetics and Genomic Sciences

Ryuichi Morishita was Associate Professor, Division of Gene Therapy Science, Osaka University Medical School. Then, he became Professor & Chairman of Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University Medical School from 2003.Professor Morishita is currently on the editorial board of over 30 scientific journals including The Open Gene Therapy Journal (Editor-in-Chief), Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry (Editor-in-Chief), Gene Therapy

Clinical Gene Therapy,Gene Therapy,ATVB, Circulation, and Cardiovascular Research.

Professor van Zandwijk's major research interest is in thoracic oncology. He founded the department of Thoracic Oncology at the Netherlands Cancer Institute and was head of department from 1985 to 2008. His department was the first to study mediastinal staging, locoregional chemotherapy and photodynamic therapy in malignant mesothelioma. In 2007, Professor van Zandwijk was asked to become the inaugural director of the purpose built Asbestos Diseases Research Institute in Sydney. Over the years he has been involved in many clinical trials, translational research and mentoring more than 20 students who have become research leaders in the own right.

Thoracic Oncology, Mesothelioma

Srdjan Denic is a Professor of Medicine in the College of Medicine and Health Sciences, UAE University, Al Ain, UAE. He has completed his fellowship training in the Mount Sinai Hospital, NY, and worked in the University Hospital, SUNY, Syracuse, NY. His current research focus is on human consanguinity and its effect on common blood disorders and malignancy.

Breast cancer,Blood Disorders

Dr. Chieko Kai is a full Professor and Director of Animal Research Center, Institute of Medical Science, the University of Tokyo since 1999, and is also a Professor of International Research Center for Infectious Diseases, in the same Institute. Professor Kai is a member of Science Council of Japan. Her major interests are mechanisms of pathogenisity of RNA viruses, and to control viral diseases. Her current research focus is on developing a novel cancer therapy using oncolytic viruses by genetic engineering

Novel cancer therapy